2023;67:e2300080
Editor's note: This text-based course is a transcript of the webinar, GLP-1s and More: Pharmacology for Diabetes Mellitus and Other Endocrine Conditions, presented by Melissa Bednarek, PT, DPT, PhD, CCS
The European Medicines Agency recommended an extension to Wegovy's marketing authorization to add an oral semaglutide formulation for weight management, describing it as the first GLP-1 receptor agonist for weight management developed for oral use in the EU
For most patients, it involves a simple, subcutaneous injection that can be performed at home after our experts have provided clear instruction and guidance
This mimics the bodys natural rhythm of growth hormone pulses throughout the day
(FDA Access Data) If you are struggling to eat enough, feel weak, have persistent reflux, or have a medical condition that affects nutrition needs, its best to check with your healthcare provider or a registered dietitian